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Background: Complex fractionated atrial electrograms (CFAEs) and high dominant frequency (DF) are
targets for atrial ﬁbrillation (AF) ablation. Although adenosine triphosphate (ATP) is known to promote
AF by shortening the atrial refractory period, its role in the pathogenesis of CFAEs and DF during AF is not
fully understood.
Methods: We recorded electrical activity from a 64-electrode basket catheter placed in the left atrium
(LA) of patients with paroxysmal AF (PAF, n¼18) or persistent AF (PerAF, n¼19) before ablation. Atrial
electrogram fractionation intervals (FIs) and DFs were measured from bipolar electrograms of each
adjacent electrode pair. Ofﬂine mean atrial FIs and DFs were obtained before bolus injection of 30 mg
ATP. Peak effect was deﬁned as an R–R interval 43 s.
Results: With ATP, the mean FI decreased (from 110.4729.1 ms to 90.5724.7 ms, Po0.0001) and DF
increased (from 6.470.6 Hz to 7.170.8 Hz, Po0.0001) in all patients. There was no difference in the FI
decrease between the two groups (20.3720.5 ms vs. 19.6714.5 ms, P¼0.6032), but the increase in
DF was signiﬁcantly greater in PAF patients (1.170.8 Hz vs. 0.370.6 Hz, P¼0.0051).
Conclusions: ATP shortens atrial FIs and increases DFs in both PAF and PerAF patients. The signiﬁcant
increase in DF in PAF patients suggests that pathophysiologic characteristics related to the frequency of
atrial fractionation change as atrial remodeling progresses.
& 2015 Japanese Heart Rhythm Society. Published by Elsevier B.V. All rights reserved.
1. Introduction
Complex fractionated atrial electrograms (CFAEs) derived from
time domain analysis and dominant frequency (DF) identiﬁed by
fast Fourier transform (FFT) spectral analysis are widely used
electrical parameters for understanding the initiation and perpe-
tuation of atrial ﬁbrillation (AF) [1–7]. CFAEs are now considered
to reﬂect simply (1) dyssynchronous activation of separate cell
groups at pivot points, (2) wave collision, far-ﬁeld potentials,
(3) critical zones of repetitive activations of AF driver(s), or (4) local
reentry circuits [1–5], whereas high DF is reported to be related to
the center of a focal-ﬁring rotor or local reentry circuit [6,7].
Clinically, CFAE and/or high-DF sites have been demonstrated as
effective targets for AF termination, suggesting their importance in
the maintenance of AF [1–7]. Nonetheless, the pathogenesis of
CFAE and DF are not fully understood. Adenosine triphosphate
(ATP) is known to promote AF by shortening the atrial action
potential duration and refractory period [8–10]. In patients with
paroxysmal AF (PAF), ATP infusion increases DF, particularly at the
pulmonary vein (PV)–left atrial (LA) junction. DF is higher in
patients with persistent AF (PerAF) than in patients with PAF at
all the LA regions surveyed, but the extent of the DF increase with
ATP is less in PerAF patients than that in PAF patients. Our
preliminary results suggest that the ability of ATP to highlight
sites driving PAF that could be targeted for ablation, whereas non-
PV locations are more likely. Jadidi et al. reported [11] that atrial
ﬁbrosis as deﬁned by delayed enhanced magnetic resonance
imaging is associated with slower and organized electrical activity
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but lower voltage than healthy atrial sites in patients with long-
lasting PerAF. Therefore, PerAF patients in the present study may
represent electrical remodeling as demonstrated by higher DF and
structural remodeling as shown by lower responses to ATP infu-
sion, possibly due to patchy ﬁbrosis around higher DF sites. In such
cases, PV isolation plus LA ablation targeted at rotors in the LA
body might be necessary. We therefore hypothesized that ATP may
spatially affect the atrial electrogram interval determined by time
domain and frequency domain analyses during AF. We investi-
gated the effects of ATP on the atrial electrogram interval and DF
characteristics in human AF, and evaluated whether these effects
are inﬂuenced by the progression of atrial remodeling.
2. Material and methods
2.1. Study patients
This study included 37 consecutive patients (36 men and one
woman; mean age 56.9710.7 years) scheduled to undergo ﬁrst
catheter ablation for AF. Eighteen had PAF (AF lasting o7 days),
and 19 had PerAF (AF lasting Z7 days). Patients with cardiomyo-
pathy, valvular heart disease, or congenital heart disease were
excluded. Adequate oral anticoagulation therapy was administered
for at least 1 month before the ablation procedure, and all
antiarrhythmia drugs were discontinued for at least 5 half-lives
before the procedure. Upon admission, transesophageal and
transthoracic echocardiography were performed, and baseline
characteristics including maximum LA volume (determined by
the prolate-ellipsoid method) and left ventricular (LV) ejection
fraction (determined by the Teichholz method) were obtained. The
study protocol was approved by the Institutional Review Board of
Nihon University Itabashi Hospital (December 7, 2012, RK-121109-
5), and all patients provided written informed consent for their
participation in the study.
2.2. Electrophysiologic studies
Electrophysiologic studies were performed under conscious
sedation using dexmedetomidine, propofol, and fentanyl as
described previously [7,12]. After vascular access was obtained,
single transseptal puncture was performed and intravenous
heparin was administered to maintain an activated clotting time
of 4300 s. After two long sheaths (one SL0 sheath and one Agilis
sheath; St. Jude Medical, Inc., St. Paul, MN) were inserted into the
LA via the transseptal puncture, the three-dimensional geometry
of the LA and four PVs was reconstructed using an EnSite NavX
mapping system (version 8.0; St. Jude Medical, Inc) and a 20-pole
circular mapping catheter with 1.5-mm interelectrode spacing
(Livewire Spiral HP catheter, St. Jude Medical, Inc.). To record
multiple bipolar signals (ﬁlter setting, 30–400 Hz) simultaneously,
we used a multi-electrode basket catheter (Constellation; EP
Technologies/Boston Scientiﬁc Corporation, San Jose, CA), which
consisted of eight splines (A–H), each with eight electrodes 4 mm
in length. The basket catheter was deployed in the LA, and the
distal end was placed at the left PV antrum (Fig. 1). A basket
catheter of adequate size (38 mm with inter-electrode spacing of
3 mm, 48 mm with inter-electrode spacing of 4 mm, or 60 mm
with interelectrode spacing of 5 mm) was chosen to allow con-
sistent contact with the LA endocardium. If the patient was in
sinus rhythm, AF was induced by rapid atrial pacing from the
coronary sinus ostium to record the CFAEs and DFs 5 min after AF
induction.
2.3. Bipolar signal recordings
Because of the limited number of electrodes that can be applied
during the use of the EnSite Classic mapping system, signals from
one proximal electrode from each spline of the basket catheter
could not be recorded. Thus, six of seven bipolar electrode pairs at
each spline totaling 48 bipolar electrograms (six pairs eight
splines) were entered into the analysis. With the basket catheter
sitting in a stable position, baseline bipolar signals from each
electrode pair representing the 48 bipolar atrial electrograms were
recorded for 5 s during AF and stored in the NavX mapping system.
2.4. Time domain atrial electrogram interval analysis
For atrial electrogram interval analysis, the NavX mapping
parameters were set to the CFAE-mean, an algorithm was used
to determine the average time of the atrial electrogram interval
(fractionation intervals [FIs]) at each site, and a color map of the
FIs was constructed [7,12,13]. The mean FI was taken as the
average time between consecutive deﬂections during 5-s record-
ing periods. The settings included a refractory period of 40 ms,
peak-to-peak sensitivity between 0.05 mV and 0.1 mV, and elec-
trogram duration of o10 ms. In addition, continuous CFAEs were
deﬁned as those with a mean FI of o50 ms and variable CFAEs as
having an FI of 50–120 ms.
2.5. FFT analysis
For FFT analysis, the DF (the highest power frequency) was
analyzed using the DF software installed in on the NavX mapping
system (sampling rate, 1200 Hz; resolution, 0.14 Hz; low-pass
ﬁlter, 20 Hz; high-pass ﬁlter, 1 Hz with a Hamming window
function) as previously reported [7,12,13]. Five-s bipolar signals
recorded during AF were used for DF analysis. A high-DF site was
deﬁned as a site with a frequency of 4 8 Hz [14,15]. The regularity
index was taken as the area within the 0.75-Hz band around the
DF divided by the area of the frequencies sampled from 3 Hz to
14 Hz [8,16]. A regularity index of o0.2 meant exclusion from
the study.
CS
Eso
Ao
Basket catheter
Fig. 1. Fluoroscopic view (anteroposterior projection) of the basket catheter
position. The catheter is positioned at the anterior portion of the left atrium,
ostium of the left atrial appendage, and antrum of the left superior pulmonary vein.
Ao, catheter positioned at the noncoronary cusp; CS, catheter positioned in the
coronary sinus; Eso, esophageal temperature monitoring catheter.
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2.6. Evaluation of FI and DF after ATP injection
We injected ATP from the sheath placed in the right jugular
vein and ﬂushed with 20 mL of saline. Bipolar signals were
recorded for 5 s after intravenous injection of 30 mg of ATP. All
bipolar electrograms recorded from the basket catheter during the
period of maximum ATP effect were analyzed ofﬂine on the NavX
mapping system. The electrophysiologic effect induced by ATP was
identiﬁed as an R–R interval of 43 s. The average FIs and DFs
recorded using the basket catheter were compared between the
PAF group and the PerAF group. The numbers and percentage
areas of CFAE and high-DF sites were also compared between the
two groups. To evaluate regional differences in CFAE and high-DF
sites, we considered the basket catheter electrodes corresponding
to the left PV antrum (the two distal bipolar pairs), the lateral LA
(the next two bipolar pairs), and the middle LA (the two proximal
bipolar pairs).
2.7. Statistical analysis
Continuous variables were expressed as means7SD or med-
ians with interquartile ranges. When values were normally dis-
tributed, between-group differences were analyzed by Student's
unpaired t test. When values were not normally distributed,
between-group differences were analyzed using the Mann–Whit-
ney U test. Fisher's exact probability test was used to analyze
differences in the distributions of dichotomous variables between
the two groups. All statistical analyses were performed with JMP
8 software (SAS Institute, Cary, NC), and a P-value o0.05 was
considered statistically signiﬁcant.
3. Results
3.1. Baseline clinical characteristics and echocardiographic variables
Table 1 shows baseline clinical characteristics and echocardio-
graphic variables for all patients per group. There were no
differences in baseline clinical characteristics between the two
groups. LA dimensions (PerAF vs. PAF: 43.376.8 vs.
36.975.5 mm, respectively, P¼0.0036), LA volumes (62.0723.1
vs. 39.7714.4 cm3, P¼0.0015), and end-systolic LV dimensions
(34.777.7 vs. 29.374.7 mm, P¼0.0167) were signiﬁcantly greater
in the PerAF group than in the PAF group.
3.2. FIs, DFs, and the distributions of CFAEs and high-DF sites
Of the 48 bipolar signals available to analyze FIs and CFAEs,
43.173.8 signals (89.577.8%) per patient were usable. The
remaining 5.073.8 bipolar signals (10.577.8%) could not be used
because of poor signal quality. For the DF recordings, 5.474.2 of
the 48 bipolar signals (11.378.8%) per patient were of poor
quality, leaving 42.674.2 bipolar signals (88.778.8%) available
for analysis. The baseline FIs and DFs and the areas of CFAEs and
high-DF sites are shown in Tables 2 and 3. The overall mean
baseline FI was 110.4729.1 ms, and the overall mean baseline DF
was 6.470.6 Hz. Although there was no signiﬁcant difference in
the baseline FI between the PAF group and the PerAF group
(108.2725.7 vs. 112.4732.6 ms, P¼0.6678), the baseline DF was
signiﬁcantly higher in the PerAF group than in the PAF group
(6.670.7 Hz vs. 6.270.5 Hz, P¼0.0429). The overall baseline
bipolar signals indicative of CFAE sites represented 32.177.3 sites
(percentage area of CFAE sites: 74.4713.9%) of the available
bipolar sites (43.173.8). The baseline percentage area of high-DF
sites, which was calculated as the number of high-DF sites
(3.773.9 sites) of all available bipolar sites (42.674.2 sites), was
8.979.9%. There were no differences in the percentage areas of
CFAE and high-DF sites between the PAF group and the PerAF
group (CFAE, 73.5714.4% vs. 75.3714.3%, P¼0.2054; high DF,
6.576.8% vs. 11.3712.0%, P¼0.2598).
3.3. Effects of ATP on the distributions of FIs and CFAEs in the two
study groups
Examples of the changes in FIs and CFAE sites after ATP
administration in the PAF and PerAF groups are shown in
Figs. 2 and 3. In both groups, the mean FI calculated from all
available bipolar electrograms recorded using a basket catheter
decreased after ATP injection and the percentage area of CFAE sites
increased, but the change in FI (red and white areas in Figs. 2 and
3) within the area of CFAE sites was greater in the PAF group than
in the PerAF group. The changes in FI and the percentage area of
CFAE sites after ATP administration in the two groups are shown in
Table 2. Among all patients, the FI decreased from 110.4729.1 to
Table 1
Baseline clinical characteristics and echocardiographic variables of all patients per study group.
Characteristic/variable All PAF PerAF P-valuea
(n¼37) (n¼18) (n¼19)
Age, years 56.9710.7 57.6712.1 56.379.5 0.7184
Sex, male (%) 36 (97.3) 18 (100) 18 (94.7) 0.2628
AF duration, days (range) 690 (375–1800) 570 (450–1800) 675 (307–1627) 0.2729
Body mass index, kg/m2 25.874.0 25.474.8 26.173.1 0.5884
Casual factors
Hypertension (%) 19 (52.8) 7 (43.8) 11 (55.0) 0.5153
Diabetes mellitus (%) 4 (11.1) 2 (12.5) 2 (10.03) 0.9061
Prior stroke (%) 4 (11.1) 1 (6.3) 3 (15.0) 0.3335
Heart failure (%) 5 (19.4) 3 (18.8) 4 (20.0) 0.7963
TTE measures
LAD (mm) 40.376.2 36.975.5 43.376.8 0.0036
LAV (cm3) 51.7719.6 39.7714.4 62.0723.1 0.0015
LVDd (mm) 49.275.9 47.175.7 51.076.0 0.0528
LVDs (mm) 32.276.5 29.374.7 34.777.7 0.0167
LVEF (%) 64.1710.5 67.876.6 61.0713.0 0.0601
LAD, left atrial dimension; LAV, left atrial volume; LVDd, left ventricular end-diastolic dimension; LVDs, left ventricular end-systolic dimension; LVEF, left ventricular ejection
fraction; PAF, paroxysmal atrial ﬁbrillation; PerAF, persistent AF; TTE, transthoracic echocardiography.
a PAF group vs. PerAF group.
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90.5724.7 ms (Po0.0001), and the percentage area of CFAE sites
increased from 74.4714.1% (32.177.3 sites) to 82.2712.6%
(35.577.2 sites) (Po0.0001). The mean FI decreased from
108.2725.7 ms to 87.9722.6 ms (P¼0.0006) in the PAF group
and from 112.4732.6 ms to 93.0726.9 ms (P¼0.0007) in the
PerAF group. The decrease in FI with ATP administration did not
differ signiﬁcantly between the two groups (20.3720.5 ms vs.
19.6714.5 ms, P¼0.6032). The mean FI at baseline CFAE sites
was 71.577.5 ms, and decreased to 65.4710.3 ms after ATP
administration (P¼0.0056) in the PAF group, but not in the PerAF
group (from 70.677.2 ms to 69.6714.7 ms, P¼0.7385). There was
no difference in the increase of the percentage area of CFAEs
between the PAF and PerAF groups (9.6713.3% vs. 6.176.1%,
P¼0.2014). ATP administration did not result in between-group
differences in either regional changes in FI or in the numbers of
CFAE sites, i.e., no difference in changes in the left PV antrum,
lateral LA, or middle LA (Table 2).
3.4. Effects of ATP on DFs and the distribution of high-DF areas in the
two study groups
Examples of post-ATP injection change in the distribution of
the high-DF sites in PAF and PerAF patients are shown in
Figs. 4 and 5. In patients with PAF, both the DF and the percentage
area of high-DF sites increased with ATP administration. In
patients in the PerAF group, the pre-ATP DF was higher and the
percentage area of DF sites was marginally greater, but the
increases observed in DF and high-DFs area with ATP injection
Table 2
Regional changes in FIs and percentage areas of CFAE sites after ATP injection in the 2 study groups.
Section Baseline Post-ATP Gradient P-valuea
FIs (ms)
PAF group Overall LA 108.2725.7 87.9722.6 20.3720.5 0.0006
Left PV antrum 99.7741.1 81.6728.4 18.1725.8 0.0084
Lateral LA 107.7727.5 90.0728.8 17.8721.6 0.0030
Middle LA 117.9722.4 92.6720.8 25.3720.9 o0.0001
PerAF group Overall LA 112.4732.6 93.0726.9 19.6714.5 o0.0001
Left PV antrum 103.8732.4 86.5728.9 17.3718.5 0.0007
Lateral LA 117.6740.3 95.9730.0 21.7721.9 0.0004
Middle LA 119.1754.8 98.1735.2 21.5727.1 0.0035
% area of CFAEs (no. of sites)
PAF group Overall LA 73.5714.4 83.1712.9 þ9.6713.3 o0.0001
(33.777.4) (38.177.1) (þ4.476.3)
Left PV antrum 26.677.2 30.575.6 þ3.976.0 0.0037
Lateral LA 24.775.9 28.074.6 þ3.375.8 0.0267
Middle LA 22.275.7 24.674.6 þ2.474.3 0.0675
PerAF group Overall LA 75.3714.3 81.1712.6 þ6.176.1 o0.0001
(30.677.1) (33.076.5) (þ2.472.4)
Left PV antrum 28.575.2 31.076.0 þ2.573.4 0.0045
Lateral LA 24.376.0 25.475.8 þ1.072.9 0.1515
Middle LA 22.477.6 25.075.6 þ2.673.7 0.0119
ATP¼adenosine triphosphate; CFAE¼complex fractionated atrial electrogram; FI¼ fractionation interval; LA¼ left atrium; PAF¼paroxysmal AF; PerAF¼persistent AF,
PV¼pulmonary vein.
a Baseline vs. post-ATP injection.
Table 3
Regional changes in DFs and percentage areas of high-DF sites after ATP injection in the two study groups.
Section Baseline Post-ATP Gradient P-valuea
DF (Hz)
PAF group Overall LA 6.270.5 7.270.7 1.170.8 o0.0001
Left PV antrum 6.170.4 7.470.7 1.270.8 o0.0001
LA lateral body 6.270.6 7.370.8 0.971.0 0.0003
LA mid body 6.270.6 7.170.8 0.970.9 0.0009
PerAF group Overall LA 6.670.7 7.070.8 0.370.6 0.0406
Left PV antrum 6.770.9 7.170.8 0.470.7 0.0372
LA lateral body 6.570.7 7.070.8 0.570.7 0.0129
LA mid body 6.670.7 6.870.8 0.170.8 0.3143
% area of high DF (no. of sites)
PAF group Overall LA 6.576.8 20.9728.6 þ14.4730.9 0.0644
(2.973.0) (9.7713.6) (þ6.8714.5)
Left PV antrum 2.072.7 8.4710.5 þ6.3711.6 0.0325
Lateral LA 1.973.0 7.179.6 þ5.2710.5 0.0516
Middle LA 2.672.8 5.579.4 þ2.9710.2 0.2418
PerAF group Overall LA 11.3712.0 19.2715.2 þ7.9716.2 0.0400
(4.474.6) (7.876.4) (þ3.476.7)
Left PV antrum 4.276.1 8.576.4 þ4.377.4 0.0193
Lateral LA 2.973.4 6.276.0 þ3.375.8 0.0245
LA mid body 4.274.9 4.574.3 þ0.377.0 0.8527
ATP, adenosine triphosphate; DF, dominant frequency; LA, left atrium; PAF, paroxysmal atrial ﬁbrillation; PerAF, persistent AF; PV, pulmonary vein.
a Baseline vs. post-ATP injection.
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were smaller than those seen in patients with PAF. Changes in DF
and percentage area of DF sites are shown in Table 3. In the total
patient group, DF increased from 6.470.6 Hz to 7.170.8 Hz
(Po0.0001) with ATP administration, and percentage area of
high-DF sites increased from 8.9710.0% (3.773.9 sites) to
20.0722.4% (8.8710.4 sites) (P¼0.0094). The DF increased from
6.270.5 Hz to 7.270.7 Hz in the PAF group (Po0.0001) and from
6.670.7 Hz to 7.070.8 Hz in the PerAF group (P¼0.0406). In the
PAF group, the percentage area of high-DF sites increased,
although not signiﬁcantly, from 6.576.8% (2.973.0 sites) to
20.9728.6% (9.7713.6 sites) (P¼0.0644) with ATP administra-
tion, and in the PerAF group, the percentage area of high-DF sites
increased from 11.3712.0% (4.474.6 sites) to 19.2715.2%
(7.876.4 sites) (P¼0.0400). Only the increase in DF was signiﬁ-
cantly greater in the PAF group than in the PerAF group
(1.170.8 Hz vs. 0.370.6 Hz, P¼0.0051). The extent of change in
the percentage area of high-DF sites after ATP administration did
not differ signiﬁcantly between the PAF group and the PerAF group
(14.4730.9% vs. 7.9716.2%, P¼0.4228). Regionally, in both
groups, the increase in DF and the percentage area of DF sites
occurred more toward the left PV antrum than in the middle and
lateral portions of the LA (Table 3).
4. Discussion
4.1. Major ﬁndings
This study revealed differences in the FIs and DFs of the LA
between patients with PAF and PerAF, and in the effects of ATP on
these parameters. There was no difference in the baseline FIs
between patients in the PAF and PerAF groups, but baseline DFs
were signiﬁcantly higher in the PerAF group. ATP shortened FIs,
widened CFAE areas, increased DFs, and increased high-DF areas in
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Fig. 2. Representative CFAE maps from a patient with PAF before and after ATP
injection. The red areas show variable CFAE sites with a mean fractionation interval
of 50–120 ms, and the white areas show continuous CFAE sites with a mean
fractionation interval of o50 ms. The mean fractionation interval calculated from
all available bipolar electrograms of the basket catheter was shortened by ATP
injection from 93.5764.6 ms to 81.8755.1 ms (P¼0.0020), and the percentage
area of CFAE sites increased from 76.6% (36 sites) to 83.0% (39 sites). AP,
anteroposterior; ATP, adenosine triphosphate; CFAE, complex fractionated electro-
gram; LAA, left atrial appendage; LIPV, left inferior pulmonary vein; LSPV, left
superior pulmonary vein; PA, posteroanterior; PAF, paroxysmal atrial ﬁbrillation;
RIPV, right inferior pulmonary vein; RSPV, right superior pulmonary vein.
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Percentage area of CFAE sites:  
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Fig. 3. Representative CFAE maps from a patient with PerAF before and after ATP
injection. The fractionation interval calculated from all available bipolar electro-
grams of the basket catheter was shortened by ATP injection from 92.2765.8 ms to
70.7730.8 ms (P¼0.0010), and the percentage area of CFAE sites increased from
80.0% (32 sites) to 87.5% (35 sites). Overall changes in CFAE by ATP seem to be
similar between the PAF case shown in Fig. 2 and this case, but the fractionation
intervals within the CFAE sites were shortened more in the PAF case than the PerAF
case. AP, anteroposterior; ATP, adenosine triphosphate; CFAE, complex fractionated
electrogram; LAA, left atrial appendage; LIPV, left inferior pulmonary vein; LSPV,
left superior pulmonary vein; PA, posteroanterior; PAF, paroxysmal atrial ﬁbrilla-
tion; PerAF, persistent atrial ﬁbrillation; RIPV, right inferior pulmonary vein; RSPV,
right superior pulmonary vein.
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Average DF:  
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Fig. 4. Representative DF maps from a patient with PAF before and after ATP
injection. The bright purple areas are high-DF sites (frequencies of 48 Hz). The
overall DF increased from 6.070.8 Hz to 6.971.1 Hz (Po0.0001) after ATP
injection, and the percentage area of high-DF sites increased from 2.1% (one site)
to 14.9% (seven sites). AP, anteroposterior; ATP, adenosine triphosphate; CFAE,
complex fractionated electrogram; DF, dominant frequency; LAA, left atrial appen-
dage; LIPV, left inferior pulmonary vein; LSPV, left superior pulmonary vein; PA,
posteroanterior; PAF, paroxysmal atrial ﬁbrillation; RIPV, right inferior pulmonary
vein; RSPV, right superior pulmonary vein.
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6.2 ± 0.9 Hz 
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Fig. 5. Representative DF maps from a patient with PerAF before and after ATP
injection. The overall DF value increased from 6.270.9 Hz to 7.070.8 Hz
(Po0.0001) after ATP injection, and the percentage area of high-DF sites increased
from 7.5% (three sites) to 12.5% (ﬁve sites). Note that in the PerAF case, baseline DF
values were higher and the percentage area of DF sites was marginally greater, but
the increases in the DF values and percentage areas of high DF by ATP injection
were smaller than those in the PAF case shown in Fig. 4. AP, anteroposterior; ATP,
adenosine triphosphate; CFAE, complex fractionated electrogram; DF, dominant
frequency; LAA, left atrial appendage; LIPV, left inferior pulmonary vein; LSPV, left
superior pulmonary vein; PA, posteroanterior; PAF, paroxysmal atrial ﬁbrillation;
PerAF, persistent atrial ﬁbrillation; RIPV, right inferior pulmonary vein; RSPV, right
superior pulmonary vein.
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both groups. The ATP-induced decreases in FIs within the CFAE
area and increases in DFs were more pronounced in the PAF group
than in the PerAF group. The increases in DFs and percentage areas
of high-DF sites in both groups occurred more frequently near the
left PV antrum than at the lateral and mid portions of the LA,
although the regional distributions of FIs and CFAEs did not differ
between sites.
4.2. FIs, CFAE distributions, DFs, and distributions of high-DF sites in
the PAF and PerAF groups
We found no signiﬁcant difference in the FIs or percentage
areas of CFAEs and high DFs between the PAF and PerAF groups.
However, the DFs were signiﬁcantly higher in PerAF patients than
in PAF patients. Our ﬁndings are consistent with those of previous
reports of shorter FIs, larger percentage areas of CFAEs, and higher
DFs in patients with LA remodeling than in those without
[7,13,16,17]. These ﬁndings may relate to the fact that the
remodeled LA in patients with PerAF increases the electrical
substrate for AF initiation and maintenance, such as that occurring
as a result of focal-ﬁring rotors or local reentry circuits.
4.3. Effects of ATP on CFAE and DF
The effects of adenosine or ATP on the atrial myocardium have
been reported previously. Adenosine and acetylcholine (ACh) are
known to activate the same Kir3.x subfamily of inward rectiﬁer
potassium channels through different signaling pathways [18].
ACh activates a speciﬁc population of Kþ channels called either IK,
ACh or IK,Ado, leading to hyperpolarization of the cell membrane
and shortening of the action potential duration and refractory
period, and suppresses both spontaneous pacemaker discharge
and early and delayed depolarizations through increased atrial Kþ
conductance [8–10]. ATP facilitates reentry as a mechanism of AF
maintenance, and can rule out an automatic or triggered mechan-
ism. In the present study, ATP increased DFs and accelerated
fractionated activity during AF. Similarly, Atienza et al. reported
that ATP shortened FI and increased the DF of the PV-LA junction
in PAF patients [3]. The results of Atienza et al.'s and the present
study showing ATP can shorten mean FI and increase DF in
patients with AF, suggesting that functional reentry plays an
important role in maintaining AF. Because Atienza et al. evaluated
limited sites in the posterior LA wall with a 20-pole spiral catheter
[3], it is unclear whether the changes in the distributions of CFAEs
or high-DF sites occurred throughout the LA. The use of a basket
catheter, which enables recording from a wider area of the LA,
demonstrated that ATP widened the overall areas of CFAEs
through an increase in electrogram fractionation in the
present study.
ATP shortened FIs, increased DFs, and increased CFAE and DF
areas in both the PAF and the PerAF group, but only the extent of
the increase in DF differed signiﬁcantly between the groups.
Similarly, Atienza et al. reported that ATP increases DFs, and that
the increase in DF is signiﬁcantly greater in the PAF patients than
in PerAF patients [8]. We found that FIs within the CFAE area were
more pronounced in the PAF group. Considering the mechanism of
AF maintenance in PAF patients, this is a reasonable ﬁnding, i.e.,
the PV antrum in these patients has undergone less electrical and
structural remodeling. Furthermore, after ATP injection, the DFs in
the PAF patients were slightly higher at the PV antrum than at
other areas in the LA, suggesting that the PV antrum might play an
important role in the initiation and maintenance of AF in patients
with PAF. The different responses of CFAE and DF sites to ATP in
the PAF vs. PerAF groups could be due to the presence of more
electrically and structurally remodeled atrial substrate in the
patients in the PerAF group. Atrial myocytes adapt to chronically
high atrial rates by down-regulation of the IK,ACh channel to
counteract the shortening of the atrial effective refractory period
resulting from electrical remodeling [19]. Furthermore, Jadidi et al.
reported that slower and more organized electrical activity
occurred at sites of atrial ﬁbrosis in patients with PerAF [11].
Because functional reentrant circuits may be interrupted by
ﬁbrosis, the degree of FI shortening and DF increase induced by
ATP might be less than that in patients with PAF.
4.4. Study limitations
This study contained a number of several limitations. The CFAE
and DF sites were identiﬁed by means of a speciﬁc algorithm
installed in the NavX mapping system. However, CFAE sites have
been shown to differ very little in electrogram recordings over 5 s
and validated extensively, and are therefore used clinically for AF
ablation [12,13,20]. LA endocardial contact with the basket cathe-
ter also posed a technical limitation. Often, it is not possible for all
of the electrodes to contact the endocardium. Furthermore, the
basket catheter has been shown to cover only up to 50% of the LA
surface [21]. No mapping of the right atrium or LA septal sites was
performed, so it remains unclear whether our ﬁndings apply to
these sites. We performed ATP injection only once because we did
not conduct right ventricle pacing to determine the maximum
effect on the atrioventricular node CFAE and DF were calculated.
Performing large-dose ATP injection twice without back-up pacing
increases patient discomfort. Therefore, we did not examine the
reproducibility of the response to ATP injection.
5. Conclusions
In both the PAF group and the PerAF group, ATP shortened the
CFAE mean cycle length associated with widening of the CFAE
area. Similarly, the DFs and percentage areas of high DF in the LA
increased after ATP injection. These data may indicate that
reentrant AF drivers can be accelerated and manifested by ATP.
The increase in DFs by ATP injection was enhanced predominantly
in the PAF group rather than in the PerAF group, which might be
due to the different AF substrates found in these different patients.
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